BR112015014243A8 - composição de vacina para uso em populações imunocomprometidas e uso da mesma - Google Patents
composição de vacina para uso em populações imunocomprometidas e uso da mesma Download PDFInfo
- Publication number
- BR112015014243A8 BR112015014243A8 BR112015014243A BR112015014243A BR112015014243A8 BR 112015014243 A8 BR112015014243 A8 BR 112015014243A8 BR 112015014243 A BR112015014243 A BR 112015014243A BR 112015014243 A BR112015014243 A BR 112015014243A BR 112015014243 A8 BR112015014243 A8 BR 112015014243A8
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- immunocompromised populations
- vaccine composition
- immunocompromised
- populations
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 206010061598 Immunodeficiency Diseases 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001932 seasonal effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12197522.1A EP2742952A1 (en) | 2012-12-17 | 2012-12-17 | Influenza vaccine composition |
| PCT/EP2013/077007 WO2014095944A1 (en) | 2012-12-17 | 2013-12-17 | Vaccine composition for use in immuno-compromised populations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015014243A2 BR112015014243A2 (pt) | 2017-07-11 |
| BR112015014243A8 true BR112015014243A8 (pt) | 2019-10-08 |
Family
ID=47358019
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015014174A BR112015014174A2 (pt) | 2012-12-17 | 2013-12-17 | composição de vacina para indivíduos virgens |
| BR112015014243A BR112015014243A8 (pt) | 2012-12-17 | 2013-12-17 | composição de vacina para uso em populações imunocomprometidas e uso da mesma |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015014174A BR112015014174A2 (pt) | 2012-12-17 | 2013-12-17 | composição de vacina para indivíduos virgens |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11065325B2 (enExample) |
| EP (4) | EP2742952A1 (enExample) |
| JP (3) | JP2016502996A (enExample) |
| KR (3) | KR20150132092A (enExample) |
| CN (3) | CN112826929A (enExample) |
| AU (2) | AU2013360890B2 (enExample) |
| BR (2) | BR112015014174A2 (enExample) |
| CA (2) | CA2895028A1 (enExample) |
| HK (2) | HK1213492A1 (enExample) |
| MX (2) | MX2015007753A (enExample) |
| RU (2) | RU2661407C2 (enExample) |
| WO (2) | WO2014095944A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101857839B1 (ko) * | 2010-09-30 | 2018-05-14 | 유로씨네 백신즈 에이비 | 개선된 백신 조성물들 |
| EP3197487B1 (en) | 2014-09-26 | 2022-08-03 | Seqirus UK Limited | Vaccination of immunocompromised subjects |
| EP4144369A1 (en) * | 2014-09-26 | 2023-03-08 | Seqirus UK Limited | Vaccination of immunocompromised subjects |
| RU2634247C2 (ru) * | 2015-09-28 | 2017-10-24 | Федеральное государственное бюджетное научное учреждение "СЕВЕРО-КАВКАЗСКИЙ ЗОНАЛЬНЫЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ВЕТЕРИНАРНЫЙ ИНСТИТУТ" (ФГБНУ СКЗНИВИ) | Способ стимуляции иммунного ответа и препарат для его осуществления |
| WO2019108928A1 (en) * | 2017-11-30 | 2019-06-06 | Ohio State Innovation Foundation | Mucoadhesive nanoparticle entrapped influenza virus vaccine delivery system |
| CN115551355B (zh) * | 2020-04-16 | 2024-11-12 | 拜耳公司 | 活性化合物结合物和包含它们的杀真菌剂组合物 |
| EP4135519B1 (en) * | 2020-04-16 | 2024-09-25 | Bayer Aktiengesellschaft | Active compound combinations and fungicide compositions comprising those |
| LT4135520T (lt) * | 2020-04-16 | 2024-12-27 | Bayer Aktiengesellschaft | Veikliųjų medžiagų deriniai ir juos apimančios fungicidų kompozicijos |
| CN112063699B (zh) * | 2020-09-16 | 2021-06-18 | 成都市疾病预防控制中心 | 一种用于研究hiv感染者免疫衰老机制的系统 |
| EP4463180A2 (en) * | 2022-01-10 | 2024-11-20 | The Children's Medical Center Corporation | Methods and compositions relating to immunization of immune distinct patients |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9602280D0 (sv) | 1996-06-10 | 1996-06-10 | Pharmatrix Ab | Immunstimulerande lipidformulering |
| SE9900496D0 (sv) | 1999-02-12 | 1999-02-12 | Pharmatrix Ab | Vaccine formulation |
| US8410248B2 (en) | 1999-03-12 | 2013-04-02 | Human Genome Sciences Inc. | HWBAO62 polypeptides |
| EP1372528B1 (en) | 2001-04-05 | 2013-01-02 | Novartis Vaccines and Diagnostics, Inc. | Mucosal boosting following parenteral priming |
| US20050208602A1 (en) | 2001-08-10 | 2005-09-22 | Rosen Craig A | 89 human secreted proteins |
| WO2004042000A2 (en) | 2002-05-17 | 2004-05-21 | Human Genome Sciences, Inc. | 157 human secreted proteins |
| WO2004047862A1 (en) | 2002-11-26 | 2004-06-10 | Eurocine Ab | Novel amine-based adjuvant |
| CN1867355A (zh) | 2003-08-11 | 2006-11-22 | 财团法人阪大微生物病研究会 | 包含诱导粘膜免疫的佐剂的新型疫苗 |
| CA2609038A1 (en) | 2005-05-18 | 2006-11-23 | Trinity Biosystems, Inc. | Methods and compositions for immunizing against chlamydia infection |
| CN103012169B (zh) | 2005-06-30 | 2016-04-20 | 卫材R&D管理有限公司 | 用于制备免疫佐剂的化合物 |
| CN101257919B (zh) | 2005-08-05 | 2012-08-29 | 国立大学法人德岛大学 | 可以由选择性产生IgA抗体向产生IgA和IgG两种抗体转换的抗原药物载体和使用该载体的经鼻·粘膜疫苗 |
| RU2323742C1 (ru) * | 2007-02-15 | 2008-05-10 | Государственное учреждение Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова (ГУ НИИВС им. И.И. Мечникова) | Способ повышения иммуногенности инактивированной гриппозной вакцины |
| WO2009071633A1 (en) | 2007-12-06 | 2009-06-11 | Glaxosmithkline Biologicals S.A. | Influenza composition |
| US20090291095A1 (en) | 2008-05-23 | 2009-11-26 | The Regents Of The University Of Michigan | Nanoemulsion adjuvants |
| US9415006B2 (en) | 2008-05-23 | 2016-08-16 | The Regents Of The University Of Michigan | Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same |
| US20130178383A1 (en) | 2008-11-12 | 2013-07-11 | David Spetzler | Vesicle isolation methods |
| WO2010138806A2 (en) | 2009-05-28 | 2010-12-02 | Curna, Inc. | Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
| KR101857839B1 (ko) | 2010-09-30 | 2018-05-14 | 유로씨네 백신즈 에이비 | 개선된 백신 조성물들 |
-
2012
- 2012-12-17 EP EP12197522.1A patent/EP2742952A1/en not_active Withdrawn
-
2013
- 2013-12-17 US US14/650,809 patent/US11065325B2/en not_active Expired - Fee Related
- 2013-12-17 AU AU2013360890A patent/AU2013360890B2/en not_active Ceased
- 2013-12-17 RU RU2015129028A patent/RU2661407C2/ru not_active IP Right Cessation
- 2013-12-17 BR BR112015014174A patent/BR112015014174A2/pt not_active Application Discontinuation
- 2013-12-17 EP EP13805935.7A patent/EP2931307B1/en not_active Not-in-force
- 2013-12-17 JP JP2015547077A patent/JP2016502996A/ja active Pending
- 2013-12-17 MX MX2015007753A patent/MX2015007753A/es unknown
- 2013-12-17 MX MX2015007688A patent/MX2015007688A/es unknown
- 2013-12-17 KR KR1020157019558A patent/KR20150132092A/ko not_active Ceased
- 2013-12-17 CA CA2895028A patent/CA2895028A1/en not_active Abandoned
- 2013-12-17 CA CA2895023A patent/CA2895023A1/en not_active Abandoned
- 2013-12-17 JP JP2015547078A patent/JP2016502997A/ja active Pending
- 2013-12-17 KR KR1020157019562A patent/KR20150132093A/ko not_active Ceased
- 2013-12-17 BR BR112015014243A patent/BR112015014243A8/pt not_active Application Discontinuation
- 2013-12-17 CN CN202110039199.9A patent/CN112826929A/zh active Pending
- 2013-12-17 EP EP18193418.3A patent/EP3431101A1/en not_active Withdrawn
- 2013-12-17 CN CN201380065877.2A patent/CN104870010A/zh active Pending
- 2013-12-17 HK HK16101591.3A patent/HK1213492A1/zh unknown
- 2013-12-17 WO PCT/EP2013/077007 patent/WO2014095944A1/en not_active Ceased
- 2013-12-17 CN CN201380065856.0A patent/CN104884085A/zh active Pending
- 2013-12-17 US US14/650,807 patent/US20150306204A1/en not_active Abandoned
- 2013-12-17 AU AU2013360889A patent/AU2013360889C1/en not_active Ceased
- 2013-12-17 KR KR1020217000812A patent/KR20210007042A/ko not_active Ceased
- 2013-12-17 RU RU2015129077A patent/RU2661408C2/ru not_active IP Right Cessation
- 2013-12-17 WO PCT/EP2013/077006 patent/WO2014095943A1/en not_active Ceased
- 2013-12-17 HK HK16100580.8A patent/HK1212611A1/zh unknown
- 2013-12-17 EP EP13811462.4A patent/EP2931308B1/en not_active Not-in-force
-
2019
- 2019-03-18 JP JP2019049330A patent/JP2019112448A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015014243A8 (pt) | composição de vacina para uso em populações imunocomprometidas e uso da mesma | |
| MD4841B1 (ro) | Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică | |
| BR112014016810A2 (pt) | composições e métodos para tratamento de distúrbios metabólicos | |
| BR112013009649A2 (pt) | composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição | |
| BR112015011447A2 (pt) | composto da fórmula i, composição farmacêutica e de vacina, e, uso de um composto | |
| BR112014011162A2 (pt) | derivados purínicos para o tratamento de infecções virais | |
| BR102013003570A8 (pt) | Composições de plasma rico em plaquetas | |
| BR112012020839A2 (pt) | vacinas para uso na profilaxe e tratamento de doença de vírus da influenza | |
| UA114086C2 (xx) | Імуногенна композиція глікопротеїну g вірусу hendra і/або nipah | |
| BR112015001313A2 (pt) | composições de vacina | |
| BR112015007366A2 (pt) | derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças | |
| EA201490610A1 (ru) | Соединения и способы усиления врожденных иммунных ответов | |
| BR112015011439A2 (pt) | composto, composição farmacêutica, composição de vacina, e, uso de um composto | |
| EA201590862A1 (ru) | Фармацевтические композиции | |
| MX369474B (es) | Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad. | |
| BR112015017966A2 (pt) | composições imunogênicas compreendendo vírus silificado e métodos de uso | |
| BR112013018642A2 (pt) | vacinas e composições contra streptococcus pneumoniae | |
| CO6761399A2 (es) | Composiciones y métodos de vacuna del virus tipo 1b de diarrea viral bovina | |
| BRPI0918806A2 (pt) | composição compreendendo quitosana para administração ocular de vaninas em aves | |
| BR112015002549A2 (pt) | regime de vacinação para proteger uma criança contra infecção ou doença causada por vírus sincicial respiratório, composição imunogênica ou pluralidade de composições imunogênicas, uso de uma composição imunogênica ou de uma pluralidade de composições imunogênicas | |
| BR112012029304A2 (pt) | copolíme-ros em bloco de polissiloxano e seu uso em formulações cosmeticas | |
| MX382924B (es) | Composición para prevenir infección por mycoplasma spp. | |
| BR112015031226A2 (pt) | Composição de vacina, e, uso da composição de vacina | |
| BR112017022755A2 (pt) | formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual | |
| BR112015018200A2 (pt) | composição mastigável para administração oral e processo para preparar a mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |